Branded Medications Only Klinic prioritizes patient safety by strictly prescribing FDA-approved branded medications only
If those signals are compressed, irritated, or reduced due to blood flow changes or nerve injury, the brain receives abnormal messages

Specific situations warranting medical advice include: Persistent nausea or vomiting that prevents adequate food or fluid intake, potentially leading to dehydration Severe abdominal pain , particularly if accompanied by fever, as this may indicate pancreatitisa rare but serious adverse effect of GLP-1 receptor agonists [1] [2] Unexplained weight loss plateau or weight regain despite adherence to the medication, which may indicate the need for dietary review or dose optimisation Signs of gallbladder disease , such as persistent right upper quadrant pain, fever, or jaundice, as rapid weight loss can increase the risk of gallstones [15] Difficulty maintaining adequate nutrition due to excessive appetite suppression or food aversions Seek urgent medical attention via NHS 111, urgent care, or A&E for severe or worsening upper abdominal pain (especially with vomiting), persistent vomiting, or signs of dehydration

According to the Wegovy Summary of Product Characteristics (SmPC), treatment should be discontinued if a patient has not lost at least 5% of their initial body weight after 12 weeks on the maintenance dose (2.4 mg once weekly)